Join BioProcess International for this free live Ask the Expert webcast.
Human error reduction should be a top priority of every organization. Our company, clients, and most importantly, our patients are heavily dependent on right first time execution. Human error is, and will likely always be, the highest contributor to deviations and batch failures. FUJIFILM Diosynth Biotechnologies is aggressively seeking to reduce human error. Using my experience in the nuclear industry, I will share a method implemented by FDB to reduce human error, and therefore increase success rates.
• How this method was implemented
• How effective the method is
• How sustainable the method is
We invite you to join Tony Fultz, Director of Upstream, for this 15 minute webcast.
Wednesday, August 23 at 11am EST